Personalized mRNA Vaccine for Melanoma Tested with Keytruda
The story in brief
A personalized mRNA vaccine from Merck and Moderna, tailored to cancer genetics, is tested with Keytruda for melanoma. Early detection is key, as non-spreading cases are curable. Family history and skin changes can raise risk. Melanoma, starting in melanocytes, spreads more easily. Knowing family history increases risk. Self-exams and checkups aid early detection. Dr. Sivendran warned against tanning lamps, while Dr. Nelson urged regular self-exams.